NextCure Inc. (NXTC) PT Lowered to $4 at Roth Capital
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Price: $8.17 +21.40%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Roth Capital analyst Tony Butler lowered the price target on NextCure Inc. (NASDAQ: NXTC) to $4.00 (from $6.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- MYR Group (MYRG) PT Lowered to $422 at Goldman Sachs
- Nomura/Instinet Upgrades Seiko Group Corp (8050:JP) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
